ZNTL

Companies
NASDAQ
Zentalis Pharmaceuticals, Inc.
Health Care
Price Chart
Overview

About ZNTL

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer

Market Cap
$754.2M
Volume
1.2M
Avg. Volume
1.2M
P/E Ratio
-0.2913165
Dividend Yield
0.00%
Employees
167.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.59
High Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ZNTL.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ZNTL shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$754.2M
Volume1.2M
P/E Ratio-0.29
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 27, 2025

PortfolioPilot Analysis

Get AI-powered insights on how ZNTL fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025